FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "QuVa Pharma, Inc.(079937015)" | 70092-662 | 70092-662-43 | Lidocaine Hydrochloride; Epinephrine | 15 mg/3 mL; 30 ug/3 mL | 2025-2 | valid | 2026-10-06 | ||
| QuVa Pharma, Inc. | 70092-662 | 70092-662-43 | Lido 0.5%-Epi 10mcg/ml(Buff)3ml NaCl syr | Lido 0.5%-Epi 10mcg/ml(Buff)3ml NaCl syr | 15 mg/3 mL; 30 ug/3 mL | 2025-2 | valid | 2026-09-18 | |
| "QuVa Pharma, Inc.(079937015)" | 70092-662 | 70092-662-43 | Lidocaine Hydrochloride; Epinephrine | 15 mg/3 mL; 30 ug/3 mL | 2025-1 | valid | 2026-10-06 | ||
| QuVa Pharma, Inc. | 70092-662 | 70092-662-43 | Lido 0.5%-Epi 10mcg/ml(Buff)3ml NaCl syr | Lido 0.5%-Epi 10mcg/ml(Buff)3ml NaCl syr | 15 mg/3 mL; 30 ug/3 mL | 2025-1 | valid | 2026-09-18 |